期刊文献+

血液系统恶性肿瘤的靶向治疗

原文传递
导出
摘要 社区卫生医疗服务需要解决的是患者的基本医疗问题,全科医生面临的大多是常见病、多发病或者是一些非常见疾病的初期处理。这是否意味着他们不需要学习、了解医学专科临床中的新知识、新进展呢?显然不是。一些临床诊断、治疗领域的新进展,虽然离基层社区医生实际应用较远,但不应该不知道。因为了解它们,不仅能更新、拓宽了自身的知识库,不落后于医学知识发展的步伐,而且能提高医生自身的素质,更多获得患者的信任,也就能更好地服务于患者。
出处 《中华全科医师杂志》 2007年第5期284-286,共3页 Chinese Journal of General Practitioners
  • 相关文献

参考文献11

  • 1Lobuglio AF, Saleh MN. Monoclonal antibody therapy of cancer. Cfit Rev Oncol Hematol, 1992,13:271-282.
  • 2Coucxmum MS, Crib Lopez AJ, White CA, et al. Treatment of patients with low B cell lymphoma with the combination of chemic anti CD20 monoclonal antibody and CHOP chemotherapy. Clin Oncol, 1999,17:268-276.
  • 3Kaminski MS, Tuck M, Regan D, et al. High response rates and durable remissions in patients with previously untreated advanced stage follicular lymphoma treated with tositumomab and iodine 131 tositumomab ( Bexxar ). Blood ,2002,100 ( 1 ) 1:356-365.
  • 4Kaminski M S. 131 I-Tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med, 2005, 352:441-449.
  • 5Kreitman RJ, Wilson WH, Bergeron K, et al. Effi-cacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapyresistant hairy-cell leukemia. N Engl J Med, 2001, 345: 241-247.
  • 6陈波斌,林果为,陆华中,范华骅,郭荣,肖娟,高跞,高峰.抗bcr/abl mRNA特异性核酶作用于靶基因的细胞内外切割实验[J].复旦学报(医学版),2003,30(3):259-262. 被引量:3
  • 7Karp JE, Gojo I, Pili R, et al. Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias. Clin Cancer Res, 2004, 10:3577-3555.
  • 8Chen HX. Expanding the clinical development of bevacizumab. Oncologist ,2004,9 Suppl 1:27-35.
  • 9Fanale MA. Monoclonal antibodies in the treatment of nonHodgkin' s lymphoma. Drugs, 2007,67:333-350.
  • 10Kisselev AF, Goldberg AL. Proteasome inhibitors: from research tools to drug candidates. Chem Biol,2001,8 :739.

二级参考文献6

  • 1Frank DK, Pace NR, Ribonuclease P. Unity and diversity in a tRNA processing ribozyme. A nnu Rev Biochem , 1998;67:153
  • 2Doherty RA, Doudna JA. Ribozyme structure and mechanisms. Annu Rev Biochem, 2000,69: 597
  • 3Cobaleda C, Sanchez-Garcia I. RNase P: from biological function to biotechnological applications. Trends in Biotechnology, 2001,19: 401
  • 4Kraus G, Geffin R, Spruill G, et al. Cross-clade inhibition of HIV-1replication and cytopathology by using RNase P-associated external guide sequences. PNAS, 2002,99: 3406
  • 5Cortez D, Kadlec L, Pendergast AM. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol , 1995,15: 5531
  • 6陈波斌,林果为,郭荣,陆华中,范华骅,肖娟,高跞,高峰.抗慢性粒细胞性白血病bcr/abl mRNA真核表达载体的构建[J].复旦学报(医学版),2003,30(1):1-3. 被引量:3

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部